Zydus Lifesciences Board meeting on May 19, 2026, to consider a proposal for buyback of fully paid-up equity shares.
The trading window for insiders remains closed until May 21, 2026, in compliance with SEBI insider trading regulations.
The intimation is made under SEBI LODR Regulations 29(1)(b) and 29(2) regarding board meeting agenda items.